Josh Wolfe - This is Who You Are Up Against - [Invest Like the Best, EP.76]

Episode Summary

Executive Summary: Patrick O'Shaughnessy interviews Lux Capital cofounder Josh Wolfe on how Lux finds outsized returns by hunting neglected, scientifically complex opportunities. Wolfe explains Lux’s contrarian, thesis-driven model, its use of randomness and optionality, and why obsession, scarcity, and rebellion often precede breakthroughs.

Main Topics: Lux Capital’s differentiated model (Priority: 5/5): Lux invests across hard science, healthcare, and core tech, avoiding crowded consumer internet categories. Randomness and optionality (Priority: 5/5): Wolfe argues discovery is nonlinear, so Lux maximizes chance encounters and information flow. Thesis-driven investing (Priority: 5/5): The firm reads widely, spots consensus blind spots, and starts companies around variant perceptions. People and founder evaluation (Priority: 4/5): Lux looks for storytellers plus operators and prefers passionate dissent over internal consensus. Special situations and capital dislocations (Priority: 4/5): Lux targets late-stage businesses at early-stage prices when risk has been removed by others. Cycle awareness and venture excess (Priority: 4/5): Wolfe warns venture is overcapitalized and says Lux is slowing pace and avoiding overheated LPs. Philosophy, entropy, and rebellion (Priority: 3/5): He ties investing to entropy, dissatisfaction, outsider thinking, and the search for what sucks.

Key Arguments: Scientific and technical complexity creates edges where others don't yet understand the market. Scarcity of attention, people, and capital can make returns attractive if Lux is early. Lux succeeds by finding problems others miss, then building companies or theses around them. Great founders combine persuasive storytelling with real operating ability. Internal disagreement can be a positive signal; unanimous excitement often hides diligence gaps. Venture returns are cyclical, and too much capital lowers future returns by inflating prices. High-quality business moats come from competitive advantage, not just market growth. Lux prefers contrarian theses where the market thinks 'do not call' but the opportunity is real.

Data Points: Lux Capital AUM: $1.5 billion - Wolfe describes the firm’s scale Most recent fund size: $400 million - He notes the latest fund raised Co-invest fund size: $300 million - He mentions a separate co-invest vehicle Curion initial capitalization: less than $3 million - The nuclear waste cleanup company was started with limited capital Curion revenue growth: from a million to 40, 80, 120, 160 million in revenue - Wolfe cites Curion’s rapid expansion after Fukushima Curion EBITDA: $40 million of EBITDA - He describes the company’s profitability before sale Curion exit multiple: 10 times - Sold to Veolia Domestic nuclear reactors: 104 - Part of the nuclear waste thesis Global reactors: 440 - Part of the nuclear waste thesis Defense cleanup budget: $6 billion - Annual spending on nuclear bomb-making material cleanup Defense cleanup share of DOE budget: a quarter of the Department of Energy budget - Context for the nuclear waste opportunity Tattoo prevalence: 40 million Americans - Market size for tattoo technology Tattoo removal economics: $60 ... $6,000 with 10 $600 laser treatments - He contrasts tattoo application vs removal costs Bill Gates boardroom detail: California pizza kitchen - Memorable early board meeting lunch at Gates’ office LP allocation example: 4% target for venture capital out of an 8% target of PE - Used to explain why Lux avoids overallocated LPs

Pivotal Quotes: "What sucks?" — Josh Wolfe: His core thesis-generation question for finding overlooked problems "Failure comes from a failure to imagine failure." — Josh Wolfe: His framework for risk management and downside analysis "You better find your niche and still be the absolute best you can within that niche." — Patrick O'Shaughnessy: His closing reflection on Wolfe’s edge and the episode’s lesson

Implications: Wolfe’s approach suggests future winners will emerge from ignored technical frontiers, so investors should watch for dislocations, not hype cycles.